- Bristol Myers CFO David V. Elkins sold 30,000 shares on April 1, 2026.
- Sales totaled about 1.9 million shares value based on weighted average prices of $61.6 and $62.05.
- Elkins held 159,248 shares directly following transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bristol-Myers Squibb Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001451604-26-000004), on April 02, 2026, and is solely responsible for the information contained therein.
Comments